Responses
Novel treatment (new drug/intervention; established drug/procedure in new situation)
Recurrent myelitis in common variable immunodeficiency successfully managed with high-dose subcutaneous immunoglobulin
Compose a Response to This Article
Other responses
No responses have been published for this article.